The Cochrane Cystic Fibrosis and Genetic Disorders Group
The Cochrane Cystic Fibrosis and Genetic Disorders Review Group is an international network of healthcare
professionals, researchers and consumers preparing, maintaining, and disseminating systematic reviews of randomised control trials in the treatment of cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism).
Activities of the Group are co-ordinated by its editorial base, located within the Institute of Child Health, University of Liverpool and based at Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
You can see our Co-ordinating Editor summarise the findings of the updated review on antibioitic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis in his podcast below.
Latest output published on the Cochrane Library
On Issue 7, 2015 of The Cochrane Library we have published a total of 143 reviews and 27 protocols. There are also 18 registered titles currently progressing to protocol status. The production of these reviews involves a network of over 900 contributors (authors, consumers and referees) throughout the world. We very much welcome interest from new consumers, referees and potential reviewers. Further information can be obtained by contacting the group.